HLA-DRB1 and HLA-DQA1 associated with immunogenicity to adalimumab therapy in patients with rheumatoid arthritis. Yap CF, Nair N, de Vries A, Loeff FC, et al. Ann Rheum Dis 2023 Sep 12:ard-2023-223955. doi: 10.1136/ard-2023-223955.

Read + Share

Amedeo Smart

Independent Medical Education

Yap CF, Nair N, de Vries A, Loeff FC, et al. HLA-DRB1 and HLA-DQA1 associated with immunogenicity to adalimumab therapy in patients with rheumatoid arthritis. Ann Rheum Dis 2023 Sep 12:ard-2023-223955. doi: 10.1136/ard-2023-223955.
PMID: 37699653